Not Yet Recruiting
Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia
NCT07411586
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States